Aharon Gil reported grant involving 43,930 shares of Neuraxis, INC at $6.28 for $276k on Aug 13, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Aug 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$275,880.40Shares × reported price
Shares traded
43,930Common Stock
Price per share
$6.28Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
80,058Direct
Trade date
Aug 13, 2026Grant
Filed
Aug 17, 2026, 6:23 PM ET4-day reporting delay
Accession
0001493152-26-038815Code A · Transaction 1219
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Jul 29, 2026Grant2,226——Trade 1218
Jul 29, 2026Grant40,068——Trade 1220
3 transaction rows in this filing. Joint filers share the same rows.

NRXS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NRXS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +14%1w ago +10%1d ago −0.2%
Returns since7d −3.3%30d +11%90d180d1y

Footnotes in full

F1: The number of shares of common stock issued as a dividend on the Series B Preferred Stock to Rosalind Master Fund L.P. and the Reporting Person were 40,068 and 2,226, respectively, and was determined by dividing the accrued and unpaid 8.5% cumulative dividends on the respective Series B Preferred Stock (from the investment date, through the applicable record or conversion date) by $2.38. F2: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer. F3: Each Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein.